17,217 Penumbra, Inc. $PEN Shares Sold by Trillium Asset Management LLC

Trillium Asset Management LLC cut its position in Penumbra, Inc. (NYSE:PEN – Free Report) by 96.4% during the 3rd quarter, HoldingsChannel.com reports. The institutional investor owned 640 shares of the company’s stock after selling 17,217 shares during the period. Trillium Asset Management LLC’s holdings in Penumbra were worth $204,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds have also recently made changes to their positions in the company. Public Employees Retirement System of Ohio bought a new position in shares of Penumbra during the 2nd quarter worth $3,454,000. Engineers Gate Manager LP increased its holdings in Penumbra by 1,536.1% in the 2nd quarter. Engineers Gate Manager LP now owns 15,003 shares of the company’s stock worth $4,737,000 after acquiring an additional 14,086 shares during the last quarter. HBK Investments L P increased its holdings in Penumbra by 12.5% in the 2nd quarter. HBK Investments L P now owns 1,838,508 shares of the company’s stock worth $580,509,000 after acquiring an additional 204,247 shares during the last quarter. Odyssean LLC increased its holdings in Penumbra by 112.2% in the 2nd quarter. Odyssean LLC now owns 9,328 shares of the company’s stock worth $2,945,000 after acquiring an additional 4,932 shares during the last quarter. Finally, Sculptor Capital LP bought a new stake in Penumbra in the 1st quarter valued at about $18,717,000. 88.88% of the stock is currently owned by institutional investors.

Penumbra Stock Up 0.0%

Penumbra stock opened at $320.96 on Monday. Penumbra, Inc. has a 1-year low of $274.55 and a 1-year high of $362.41. The firm has a market capitalization of $12.65 billion, a price-to-earnings ratio of 80.85 and a beta of 0.71. The company has a current ratio of 5.89, a quick ratio of 3.92 and a debt-to-equity ratio of 0.01. The firm has a 50 day simple moving average of $320.18 and a 200 day simple moving average of $326.09.

Penumbra (NYSE:PEN – Get Free Report) last issued its earnings results on Thursday, October 29th. The company reported $1.07 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.20 by ($0.13). The business had revenue of $410.15 million for the quarter, compared to the consensus estimate of $401.41 million. Penumbra had a net margin of 10.06% and a return on equity of 10.39%. The company’s revenue was up 15.6% compared to the same quarter last year. During the same period in the previous year, the firm earned $0.97 EPS. On average, analysts predict that Penumbra, Inc. will post 4.96 earnings per share for the current year.

Analyst Upgrades and Downgrades

Several research firms have commented on PEN. Zacks Research raised shares of Penumbra from a “strong sell” rating to a “hold” rating in a report on Monday, August 24th. Weiss Ratings upgraded shares of Penumbra from a “hold (c)” rating to a “hold (c+)” rating in a research report on Friday, October 30th. Three investment analysts have rated the stock with a Buy rating and fourteen have assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus target price of $367.07.

Get Our Latest Stock Analysis on Penumbra

About Penumbra

(Free Report)

Penumbra, Inc. is a medical technology company that develops and markets devices for treating vascular conditions. Its products are used in neurovascular procedures, including the treatment of ischemic stroke and aneurysms, and in peripheral vascular procedures involving conditions such as pulmonary embolism and deep vein thrombosis. The company’s offerings include aspiration and mechanical thrombectomy systems, embolization coils, and related catheter-based devices. Penumbra was founded in 2004 and is headquartered in Alameda, California.

See Also

Want to see what other hedge funds are holding PEN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Penumbra, Inc. (NYSE:PEN – Free Report).

Institutional Ownership by Quarter for Penumbra (NYSE:PEN)

Receive News & Ratings for Penumbra Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Penumbra and related companies with MarketBeat.com's FREE daily email newsletter.